−0.43USD
−81.10 MUSD
325.11 MUSD
61.29 M
About Cellebrite DI Ltd.
Sector
Industry
CEO
Yossi Carmil
Website
Headquarters
Petach Tikva
Employees (FY)
1.01 K
Founded
1999
ISIN
IL0011794802
FIGI
BBG000BK00N6
Cellebrite DI Ltd. engages in the provision of digital investigative solutions for the public and private sectors, empowering organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. Its services include training and advisory, value realization, advanced services, and technical customer support. The firm also offers software solutions and analytic tools designed to accelerate digital investigations and address the growing complexity of handling crime and security challenges in the digital era. The company was founded on April 13, 1999 and is headquartered in Petach Tikva, Israel.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of CLBT is 10.38 USD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Cellebrite DI Ltd. stocks are traded under the ticker CLBT.
Cellebrite DI Ltd. is going to release the next earnings report on May 23, 2024. Keep track of upcoming events with our Earnings Calendar.
CLBT stock is 2.32% volatile and has beta coefficient of 1.51. Check out the list of the most volatile stocks — is Cellebrite DI Ltd. there?
One year price forecast for Cellebrite DI Ltd. has a max estimate of 16.00 USD and a min estimate of 12.00 USD.
CLBT earnings for the last quarter are 0.03 USD whereas the estimation was 0.03 USD which accounts for 17.37% surprise. Estimated earnings for the next quarter are 0.03 USD. See more details about Cellebrite DI Ltd. earnings.
Cellebrite DI Ltd. revenue for the last quarter amounts to 84.18 M USD despite the estimated figure of 82.13 M USD. In the next quarter revenue is expected to reach 85.56 M USD.
Yes, you can track Cellebrite DI Ltd. financials in yearly and quarterly reports right on TradingView.
CLBT stock has fallen by 5.29% compared to the previous week, the month change is a 9.19% fall, over the last year Cellebrite DI Ltd. has showed a 82.43% increase.
CLBT net income for the last quarter is −14.65 M USD, while the quarter before that showed 6.50 M USD of net income which accounts for −325.34% change. Track more Cellebrite DI Ltd. financial stats to get the full picture.
Today Cellebrite DI Ltd. has the market capitalization of 2.13 B, it has increased by 3.05% over the last week.
No, CLBT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CLBT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cellebrite DI Ltd. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 1.01 K employees. See our rating of the largest employees — is Cellebrite DI Ltd. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Cellebrite DI Ltd. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Cellebrite DI Ltd. stock shows the buy signal. See more of Cellebrite DI Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Cellebrite DI Ltd. future price: according to them, CLBT price has a max estimate of 16.00 USD and a min estimate of 12.00 USD. Read a more detailed Cellebrite DI Ltd. forecast: see what analysts think of Cellebrite DI Ltd. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Cellebrite DI Ltd. EBITDA is 43.29 M USD, and current EBITDA margin is 13.32%. See more stats in Cellebrite DI Ltd. financial statements.